GV 196771

Drug Profile

GV 196771

Latest Information Update: 21 Jan 2003

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Non-opioid analgesics; Small molecules
  • Mechanism of Action Glycine antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 21 Jan 2003 A study has been added to the Pain Control therapeutic trials section
  • 05 Sep 2000 Discontinued-II for Pain in European Union (Unknown route)
  • 22 Sep 1999 A preclinical study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top